Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This observational study found that patients with various skin diseases across 17 European countries experience higher levels of perceived stigmatization than skin-healthy controls, particularly those with psoriasis, atopic dermatitis, alopecia, and bullous disorders, with factors such as disease severity and psychological distress influencing stigmatization levels.

This study reported that a large proportion of US adults with physician-diagnosed alopecia areata experience substantial emotional and mental health comorbidities and report significant stigma across all disease severities, yet few are receiving counseling or therapeutic intervention.

This study demonstrated that individuals with alopecia areata in Japan experience significant stigma and mental health issues, with perceived stigma and dissatisfaction with hair growth negatively correlated with disease severity.

This study found that 54% of alopecia areata patients attributed their condition to stress, which was linked to higher perceived personal control and significant emotional impacts.

This study examined perceptions of stress as a cause of alopecia areata among individuals in a French online cohort, finding that over half of patients considered stress a contributing factor. Additionally, patients with less understanding of their condition experienced higher levels of perceived stigma.

This study found that participants perceived bald men more negatively based on facial expressions and reported varied body dissatisfaction, which was weakly linked to wellbeing and muscularity behaviors.

This cross-sectional survey found that individuals with alopecia areata and androgenetic alopecia perceived stigmatization and impaired quality of life, with greater stigma reported in German-speaking participants; factors like gender, age, and disease severity influenced stigmatization levels.

This study found that self-stigma is common among alopecia areata patients, with 85% experiencing it to some degree, and that factors like increased social support and illness acceptance correlate with lower stigmatization levels, while helplessness correlates with higher levels.

This study found that vitiligo elicited the most compassion and curiosity among general adults viewing AI-generated images of chronic skin diseases, while psoriasis was linked to higher perceptions of disgust and blame.

This study explores the social and cultural impacts of hair loss, highlighting that it is perceived as a negative or stigmatizing experience by both women undergoing chemotherapy and men with androgenic alopecia.

This paper examines how societal constructs of gender influence the treatment of idiopathic hirsutism in women, emphasizing the impact of perceived femininity on psychological stress and commercial depilatory actions.

This study found that women with PCOS reported higher overall psychological distress, but there was no significant link between their perceived hirsutism and this distress.

People with facial disfigurements are judged more negatively, highlighting the social benefits of corrective surgery.

This review found that despite varied levels of stigmatization reported in studies, hair loss generally leads to stigmatization and a reduced quality of life, but specific research on this stigma is limited.

In this narrative review, the authors found that stigma related to oculocutaneous albinism in Africa is primarily driven by socio-cultural beliefs and structural inequities, affecting individuals' health, education, and psychosocial well-being, with interventions needed to dispel myths and provide specialized healthcare and support.

This observational study provides cause-specific mortality estimates to help patients and physicians better understand long-term outcomes for localized prostate cancer based on initial treatment choices.

A girl with red hair developed hair-pulling and body image disorders after being bullied for her hair color.

This cross-sectional survey study found that stigmatizing attitudes toward people with alopecia are present in various social and professional settings, with stigma levels varying by alopecia severity and perceptions of its medical nature.

This review identified several changeable psychosocial factors, like acceptance, as potential targets for interventions aimed at reducing self-stigma and improving mental health in affected individuals.

This study found that the psychosocial impact of AA is more strongly related to patients' illness perceptions and stigma than to the severity of the disease.

People with alopecia who are more resilient tend to feel less stressed.

In this study, a mixed-methods survey of 357 balding men revealed that baldness is structurally stigmatized, with many participants experiencing distress and using treatments to combat it; others resisted stigma and expressed minimal distress.

In this review, the authors reported that past concerns linking spironolactone to an increased risk of breast cancer are unfounded, citing recent studies that confirm no such association, indicating spironolactone's potential as a treatment for alopecia in women without fear of cancer recurrence.

In this study, cancer patients aged 30 to 50 reported experiencing diagnostic delays, coping through self-advocacy, and facing stigma-related challenges such as alopecia. The authors concluded that improved physician awareness, tailored screening, and addressing stigma are essential for enhancing care for early-onset colorectal cancer patients.

This study found that individuals with androgenetic alopecia experience significantly higher symptoms of anxiety, depression, and stress compared to controls, along with reduced self-esteem and life satisfaction, highlighting the importance of addressing psychological well-being in clinical treatments.

This editorial examines how GLP-1 receptor agonists, providing significant weight loss and cardiovascular benefits, can be integrated into a comprehensive obesity treatment alongside diet and lifestyle changes, but highlights the need for further guidance on their real-world application and multidisciplinary care.

This study developed and initially validated the Scale of Alopecia Areata Distress (SAAD), a 41-item tool designed to measure psychosocial distress among US adults with alopecia areata.

This study highlighted the complex stigma, misinformation, and coping mechanisms among unmarried women with PCOS in Pakistan, emphasizing the role of family support and accurate information in managing emotional well-being.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

This study found that among patients with alopecia areata, 82% reported experiencing at least one significant life event perceived as strainful in the two years before disease onset, suggesting an association between perceived stress and the onset of this condition.